BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1-Reference-Cited by-同舟云学术

BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1

Published:2003-06-08 Issue:7 Volume:4 Page:670-679
ISSN:1529-2908
Container-title:Nature Immunology
language:en
Short-container-title:Nat Immunol

Author:

Watanabe Norihiko,Gavrieli Maya,Sedy John R,Yang Jianfei,Fallarino Francesca,Loftin Susan K,Hurchla Michelle A,Zimmerman Natalie,Sim Julia,Zang Xingxing,Murphy Theresa L,Russell John H,Allison James P,Murphy Kenneth M

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/ni944.pdf

Reference51 articles.

1. Coyle, A.J. & Gutierrez-Ramos, J.C. The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function. Nat. Immunol. 2, 203–209 (2001).

2. Hutloff, A. et al. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 397, 263–266 (1999).

3. Swallow, M.M., Wallin, J.J. & Sha, W.C. B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFα. Immunity 11, 423–432 (1999).

4. Yoshinaga, S.K. et al. T-cell co-stimulation through B7RP-1 and ICOS. Nature 402, 827–832 (1999).

5. Ling, V. et al. Cutting edge: identification of GL50, a novel B7-like protein that functionally binds to ICOS receptor. J. Immunol. 164, 1653–1657 (2000).

Cited by 739 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genome-wide mapping of the binding sites of myocyte enhancer factor 2A in chicken primary myoblasts;Poultry Science;2024-10

2. The molecular landscape of T cell exhaustion in the tumor microenvironment and reinvigoration strategies;International Reviews of Immunology;2024-09-11

3. Assessing the causal relationship between immune cell and Parkinson's disease by bi-directional Mendelian randomization analysis;2024-09-03

4. Targeting B and T lymphocyte attenuator regulates lupus disease development in NZB/W mice;2024-06-02

5. BTLA deficiency promotes HSC activation and protects against hepatic ischemia-reperfusion injury;Hepatology Communications;2024-06